(Q44247933)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Sheldon Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

M Carmen Iglesias-de la Cruz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Belinda Jim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Motohide Isono

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Fuad N Ziyadeh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

language of work or name

English

0 references

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

Biochemical and Biophysical Research Communications

15 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

16-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

The natural history of diabetic nephropathy in type I diabetes and the role of metabolic control in its prevention, reversibility and clinical course

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Mesangial matrix modulation and glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Glycated albumin stimulates TGF-beta 1 production and protein kinase C activity in glomerular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Reversal of lesions of diabetic nephropathy after pancreas transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Studies in the diabetic mutant mouse: V. Glucose tolerance in mice homozygous and heterozygous for the diabetes (db) gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

7 January 2021

Leptin and renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Structural-functional relationships in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Evolution of diabetic nephropathy in kidney grafts. Evidence that a simultaneously transplanted pancreas exerts a protective effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

The Development of Lesions in the Glomerular Basement Membrane and Mesangium After Transplantation of Normal Kidneys to Diabetic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into non-diabetic recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Lifelong prevention of mesangial enlargement by whole pancreas transplantation in rats with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Reversal of mesangial enlargement in rats with long-standing diabetes by whole pancreas transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Effect of antihypertensive therapy on renal injury in type 2 diabetic rats with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Does ACE inhibition slow progression of glomerulopathy in patients with Type 2 diabetes mellitus?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Early glomerulopathy is present in young, type 1 (insulin-dependent) diabetic patients with microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Glomerular structural changes and structural-functional relationships at early stage of diabetic nephropathy in Japanese type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

The renal risks of smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902708-0

10.1016/S0006-291X(02)02708-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12480514%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference